» Authors » Fabrice Lesage

Fabrice Lesage

Explore the profile of Fabrice Lesage including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 38
Citations 418
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Thy M, Kecili F, Urien S, Bouazza N, Foissac F, Froelicher Bournaud L, et al.
Expert Opin Drug Metab Toxicol . 2024 Dec; :1-9. PMID: 39692096
Background: Limited data exist on how continuous renal replacement therapy (CRRT) affects antimicrobial dosing in pediatric patients. This study examined the impact of pediatric CRRT parameters on the pharmacokinetics (PK)...
2.
Schweitzer-Chaput A, Callot D, Bouazza N, Lesage F, Oualha M, Paret N, et al.
BMC Pediatr . 2023 Jun; 23(1):321. PMID: 37355586
Purpose: To characterize clinical profile of pediatric local anesthetic (LA) systemic toxicity (LAST) and to identify determinants of life-threatening outcomes. Methods: Spontaneous reports notified to the French Pharmacovigilance Network were...
3.
Lefevre N, Le Gouez M, Lesage F, Rousseau V, Giuseppi A, Abadie V, et al.
Eur J Pediatr . 2022 Dec; 182(2):889-897. PMID: 36515705
Conclusions: Post-operative ventilation and feeding management strategies may represent an opportunity for quality-of-care improvement to positively impact long-term outcomes after primary esophageal atresia repair. What Is Known: • Children operated...
4.
Thy M, Urien S, Foissac F, Bouazza N, Gana I, Bille E, et al.
Antimicrob Agents Chemother . 2022 Nov; 66(12):e0113522. PMID: 36342152
We aimed to develop a piperacillin population pharmacokinetic (PK) model in critically ill children receiving continuous renal replacement therapy (CRRT) and to optimize dosing regimens. The piperacillin plasma concentration was...
5.
Thy M, Urien S, Bouazza N, Foissac F, Gana I, Bille E, et al.
Clin Pharmacokinet . 2022 Oct; 61(11):1609-1621. PMID: 36251162
Background And Objective: We aimed to develop a meropenem population pharmacokinetic model in critically ill children receiving continuous renal replacement therapy and simulate dosing regimens to optimize patient exposure. Methods:...
6.
Vedrenne-Cloquet M, Khirani S, Khemani R, Lesage F, Oualha M, Renolleau S, et al.
Thorax . 2022 Jul; 78(1):97-105. PMID: 35803726
This review aims to: (1) describe the rationale of pleural (P) and transpulmonary (P) pressure measurements in children during mechanical ventilation (MV); (2) discuss its usefulness and limitations as a...
7.
Medjebeur Hanna R, Levy M, Bille E, Hennequin C, Lesage F, Naudin J, et al.
Paediatr Drugs . 2021 Jun; 23(4):395-401. PMID: 34142330
Objectives: This study aimed to assess the incidence of amikacin plasma peak concentration (C) below 60 mg·L in critically ill children receiving an amikacin dosing regimen of 30 mg kg·day....
8.
Beranger A, Farkh C, Ahmed Elie S, Callot D, Desguerre I, Pallet N, et al.
Therapie . 2021 Mar; 76(6):751-754. PMID: 33743990
No abstract available.
9.
Beranger A, Benaboud S, Urien S, Nguyen-Khoa T, Gana I, Toubiana J, et al.
Br J Clin Pharmacol . 2020 Aug; 87(3):1275-1281. PMID: 32737909
Aims: Glomerular filtration rate (GFR) is difficult to assess in critically ill children using gold standard method and alternatives are needed. This study aimed to determine the most accurate GFR...
10.
Heilbronner C, Berteloot L, Tremolieres P, Dupic L, de Saint Blanquat L, Lesage F, et al.
Br J Haematol . 2020 May; 190(1):e21-e24. PMID: 32420608
No abstract available.